1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Biofilms Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Biofilms Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Biofilms Treatment Market Regional Analysis
6.2 North America Biofilms Treatment Market Revenue 2017-2027 (US$ Million)
6.3 North America Biofilms Treatment Market Forecast Analysis
7. North America Biofilms Treatment Market Analysis – by Product
7.1 Debridement Equipment
- 7.1.1 Overview
- 7.1.2 Debridement Equipment: North America Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Gauzes and Dressings
- 7.2.1 Overview
- 7.2.2 Gauzes and Dressings: North America Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Grafts and Matrices
- 7.3.1 Overview
- 7.3.2 Grafts and Matrices: North America Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Biofilms Treatment Market Analysis – by Wound
8.1 Traumatic and Surgical Wounds
- 8.1.1 Overview
- 8.1.2 Traumatic and Surgical Wounds: North America Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Diabetic Foot Ulcers
- 8.2.1 Overview
- 8.2.2 Diabetic Foot Ulcers: North America Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Pressure Ulcers
- 8.3.1 Overview
- 8.3.2 Pressure Ulcers: North America Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Venous Leg Ulcers
- 8.4.1 Overview
- 8.4.2 Venous Leg Ulcers: North America Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Biofilms Treatment Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Home Care Settings
- 9.2.1 Overview
- 9.2.2 Home Care Settings: North America Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America Biofilms Treatment Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Biofilms Treatment Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 North America Biofilms Treatment Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Biofilms Treatment Market Breakdown, by Product
- 10.2.1.1.2 US: North America Biofilms Treatment Market Breakdown, by Wound
- 10.2.1.1.3 US: North America Biofilms Treatment Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Biofilms Treatment Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Biofilms Treatment Market Breakdown, by Wound
- 10.2.1.2.3 Canada: North America Biofilms Treatment Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Biofilms Treatment Market Breakdown, by Product
- 10.2.1.3.2 Mexico : North America Biofilms Treatment Market Breakdown, by Wound
- 10.2.1.3.3 Mexico : North America Biofilms Treatment Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Smith & Nephew
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 MiMedx
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 ConvaTec Group Plc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Coloplast Group
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Mölnlycke Health Care AB.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Organogenesis Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Integra Life Sciences Corporation
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 B. Braun Melsungen AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Hartman Group
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Medline Industries, Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations